| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2016 | Jun 21, 2016 | Levitsky Hyam EVP Research CSO | Sell | Juno Therapeutics, Inc. | JUNO | $42.77 | $531,081 | -9.62% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.